Discovering drugs for the treatment of Ebola virus

Abstract

Drug development for Ebola virus (EBOV) has been in progress for several decades, primarily fueled by concerns about the potential use of the Category A agent as a potential bioweapon. However, the unprecedented magnitude and scale of the 2014-2016 outbreak in West Africa, combined with the potential spread to other corners of the world, led to a renewed focus on medical countermeasures for Ebola virus disease (EVD).

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 04, 2017
Accession Number
AD1038259

Entities

People

  • Allen J. Duplantier
  • Sandra L Bixler
  • Sina Bavari

Organizations

  • United States Army Medical Research Institute of Infectious Diseases

Tags

DTIC Thesaurus Topics

  • Blood
  • Blood Proteins
  • Cells
  • Chemistry
  • Clinical Trials
  • Cytokines
  • Ebola Virus
  • Epithelial Cells
  • Interferon
  • Macrophages
  • Proteins
  • Rna Viruses
  • Rodents
  • Therapy
  • Viral Load
  • Virus Diseases
  • Viruses

Fields of Study

  • Biology

Readers

  • Educational Psychology
  • Infectious Disease/Epidemiology
  • Oncology